U.S.-Japan Cooperative Medical Sciences Program Collaborative Awards

The Early-stage FY 2024 Infectious Diseases and Immunology Research: U.S.-Japan Cooperative Medical Sciences Program Collaborative Awards invite binational or multinational teams to pursue cutting-edge studies in infectious diseases and immunology, with joint funding from AMED (Japan) and NIAID (USA).

Key Information:

• R&D Phases: Basic, Applied, Nonclinical/Pre-clinical, Clinical Research

• Research Areas: Infectious Diseases & Immunology; Project for Seeds Development & Research Base

• Award Size: USD 60 000 per project, disbursed 50 % in JFY 2024 and 50 % in JFY 2025

• Research Period: JFY 2024–JFY 2025

• Expected Awards: 4–6 projects

Eligibility:

• Collaborative teams with investigators from:

  1. Japan + USA, or

  2. Japan + USA + other Asia-Pacific country(ies)

• Each application must designate both a Japanese sub-team PI and a U.S. sub-team PI who is an early-stage or female investigator

• Host institutions in Japan must contract via AMED and meet AMED’s terms & conditions

How to Apply:

1. Title & Abstract: Email [email protected] by May 20, 2024 (replace “AT” with “@”).

2. Full Proposal: Submit through CRDF Global’s portal by June 3, 2024.

3. Japanese Sub-team: Complete e-Rad registration by June 5, 2024.

4. Follow formats and guidelines in the Request for Proposals and AMED Supplemental Application Guideline (Japanese).

Contact:

AMED, Dept. of International Strategy, Division of Research Programs

Tel: +81-3-6870-2216
Email: [email protected]